Effects of modulation of the NO/cGMP pathway in tumor cell lines derived from the upper airway tract

Nektarios Papapetropoulos, Zongmin Zhou, Charis Roussos, Panagiotis Goumas, Andreas Papapetropoulos

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Nitric oxide (NO) is known to be expressed in a variety of cell types and exert its effects through autocrine and paracrine mechanisms. To characterize the NO/cGMP pathway in tumor cells of the upper airway tract, we studied the cell lines Detroit 562, FaDu and FAT7. Using isoform-specifi c antibodies, we were unable to detect expression of NO synthases in the above-mentioned cells lines. To evaluate whether tumor cells respond to NO, we exposed cells to the NO donor sodium nitroprusside (SNP). Stimulation of Detroit 562 and FaDu with SNP (10 μgrave; mol/l to 1 mmol/l) led to a concentrationdependent increase in cGMP accumulation. In addition, incubation of cells with SNP, but not 8 Br-cGMP, reduced Detroit 562 cell number. As exposure of cells to SNP decreased 3H-thymidine incorporation without inducing DNA fragmentation, we attributed the observed decrease in cell number to inhibition of cell proliferation rather than induction of apoptosis. On the other hand, exposure of Detroit 562 to high concentrations of SNP (1 mmol/l) led to apoptosis and increased the release of vascular endothelial growth factor. We conclude that, although human cell lines derived from the upper airway tract do not produce NO, they respond to NO released by neighboring cells and that exposure to NO exerts an anti- proliferative/apoptotic effect that is independent of cGMP generation.

Original languageEnglish (US)
Pages (from-to)167-176
Number of pages10
JournalPharmacology
Volume72
Issue number3
DOIs
StatePublished - Oct 27 2004
Externally publishedYes

Fingerprint

Tumor Cell Line
Nitric Oxide
Nitroprusside
Cell Line
Cell Count
Apoptosis
Nitric Oxide Donors
DNA Fragmentation
Nitric Oxide Synthase
Thymidine
Vascular Endothelial Growth Factor A
Neoplasms
Protein Isoforms
Cell Proliferation
Antibodies

Keywords

  • Apoptosis
  • cGMP
  • Nitric oxide
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of modulation of the NO/cGMP pathway in tumor cell lines derived from the upper airway tract. / Papapetropoulos, Nektarios; Zhou, Zongmin; Roussos, Charis; Goumas, Panagiotis; Papapetropoulos, Andreas.

In: Pharmacology, Vol. 72, No. 3, 27.10.2004, p. 167-176.

Research output: Contribution to journalArticle

Papapetropoulos, Nektarios ; Zhou, Zongmin ; Roussos, Charis ; Goumas, Panagiotis ; Papapetropoulos, Andreas. / Effects of modulation of the NO/cGMP pathway in tumor cell lines derived from the upper airway tract. In: Pharmacology. 2004 ; Vol. 72, No. 3. pp. 167-176.
@article{febb4c27cebb4416897350d8fa0b6939,
title = "Effects of modulation of the NO/cGMP pathway in tumor cell lines derived from the upper airway tract",
abstract = "Nitric oxide (NO) is known to be expressed in a variety of cell types and exert its effects through autocrine and paracrine mechanisms. To characterize the NO/cGMP pathway in tumor cells of the upper airway tract, we studied the cell lines Detroit 562, FaDu and FAT7. Using isoform-specifi c antibodies, we were unable to detect expression of NO synthases in the above-mentioned cells lines. To evaluate whether tumor cells respond to NO, we exposed cells to the NO donor sodium nitroprusside (SNP). Stimulation of Detroit 562 and FaDu with SNP (10 μgrave; mol/l to 1 mmol/l) led to a concentrationdependent increase in cGMP accumulation. In addition, incubation of cells with SNP, but not 8 Br-cGMP, reduced Detroit 562 cell number. As exposure of cells to SNP decreased 3H-thymidine incorporation without inducing DNA fragmentation, we attributed the observed decrease in cell number to inhibition of cell proliferation rather than induction of apoptosis. On the other hand, exposure of Detroit 562 to high concentrations of SNP (1 mmol/l) led to apoptosis and increased the release of vascular endothelial growth factor. We conclude that, although human cell lines derived from the upper airway tract do not produce NO, they respond to NO released by neighboring cells and that exposure to NO exerts an anti- proliferative/apoptotic effect that is independent of cGMP generation.",
keywords = "Apoptosis, cGMP, Nitric oxide, Vascular endothelial growth factor",
author = "Nektarios Papapetropoulos and Zongmin Zhou and Charis Roussos and Panagiotis Goumas and Andreas Papapetropoulos",
year = "2004",
month = "10",
day = "27",
doi = "10.1159/000080101",
language = "English (US)",
volume = "72",
pages = "167--176",
journal = "Pharmacology",
issn = "0031-7012",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Effects of modulation of the NO/cGMP pathway in tumor cell lines derived from the upper airway tract

AU - Papapetropoulos, Nektarios

AU - Zhou, Zongmin

AU - Roussos, Charis

AU - Goumas, Panagiotis

AU - Papapetropoulos, Andreas

PY - 2004/10/27

Y1 - 2004/10/27

N2 - Nitric oxide (NO) is known to be expressed in a variety of cell types and exert its effects through autocrine and paracrine mechanisms. To characterize the NO/cGMP pathway in tumor cells of the upper airway tract, we studied the cell lines Detroit 562, FaDu and FAT7. Using isoform-specifi c antibodies, we were unable to detect expression of NO synthases in the above-mentioned cells lines. To evaluate whether tumor cells respond to NO, we exposed cells to the NO donor sodium nitroprusside (SNP). Stimulation of Detroit 562 and FaDu with SNP (10 μgrave; mol/l to 1 mmol/l) led to a concentrationdependent increase in cGMP accumulation. In addition, incubation of cells with SNP, but not 8 Br-cGMP, reduced Detroit 562 cell number. As exposure of cells to SNP decreased 3H-thymidine incorporation without inducing DNA fragmentation, we attributed the observed decrease in cell number to inhibition of cell proliferation rather than induction of apoptosis. On the other hand, exposure of Detroit 562 to high concentrations of SNP (1 mmol/l) led to apoptosis and increased the release of vascular endothelial growth factor. We conclude that, although human cell lines derived from the upper airway tract do not produce NO, they respond to NO released by neighboring cells and that exposure to NO exerts an anti- proliferative/apoptotic effect that is independent of cGMP generation.

AB - Nitric oxide (NO) is known to be expressed in a variety of cell types and exert its effects through autocrine and paracrine mechanisms. To characterize the NO/cGMP pathway in tumor cells of the upper airway tract, we studied the cell lines Detroit 562, FaDu and FAT7. Using isoform-specifi c antibodies, we were unable to detect expression of NO synthases in the above-mentioned cells lines. To evaluate whether tumor cells respond to NO, we exposed cells to the NO donor sodium nitroprusside (SNP). Stimulation of Detroit 562 and FaDu with SNP (10 μgrave; mol/l to 1 mmol/l) led to a concentrationdependent increase in cGMP accumulation. In addition, incubation of cells with SNP, but not 8 Br-cGMP, reduced Detroit 562 cell number. As exposure of cells to SNP decreased 3H-thymidine incorporation without inducing DNA fragmentation, we attributed the observed decrease in cell number to inhibition of cell proliferation rather than induction of apoptosis. On the other hand, exposure of Detroit 562 to high concentrations of SNP (1 mmol/l) led to apoptosis and increased the release of vascular endothelial growth factor. We conclude that, although human cell lines derived from the upper airway tract do not produce NO, they respond to NO released by neighboring cells and that exposure to NO exerts an anti- proliferative/apoptotic effect that is independent of cGMP generation.

KW - Apoptosis

KW - cGMP

KW - Nitric oxide

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=5644243029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644243029&partnerID=8YFLogxK

U2 - 10.1159/000080101

DO - 10.1159/000080101

M3 - Article

VL - 72

SP - 167

EP - 176

JO - Pharmacology

JF - Pharmacology

SN - 0031-7012

IS - 3

ER -